| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
79,820,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
5,030,402 |
Avg
Vol: |
2,282,818 |
| 52
Week Range: |
$14.01 - $14.01 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Batty John |
Chief Financial Officer |
• – – |
2008-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
9,200 |
39,200 |
|
- |
|
| King Kevin M |
President |
• – – |
2008-01-08 |
4 |
D |
$22.69 |
$86,290 |
D/D |
(3,803) |
53,656 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-10-18 |
4/A |
AS |
$28.00 |
$40,460 |
D/D |
(1,445) |
14,750 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-10-18 |
4 |
AS |
$28.00 |
$63,000 |
D/D |
(2,250) |
13,945 |
|
- |
|
| Loucks Vernon R Jr |
Director |
– • – |
2007-08-28 |
4 |
S |
$22.65 |
$458,784 |
D/D |
(20,132) |
3,200 |
|
- |
|
| Loucks Vernon R Jr |
Director |
– • – |
2007-08-28 |
4 |
S |
$23.00 |
$73,657 |
D/D |
(3,200) |
0 |
|
- |
|
| King Kevin M |
EVP & Pres., Life Sciences |
• – – |
2007-08-08 |
4 |
S |
$27.33 |
$327,960 |
D/D |
(12,000) |
57,459 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-07-09 |
4 |
AS |
$26.00 |
$260,000 |
D/D |
(10,000) |
16,195 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-07-09 |
4 |
OE |
$19.34 |
$193,350 |
D/D |
10,000 |
26,195 |
|
- |
|
| King Kevin M |
EVP & Pres., Life Sciences |
• – – |
2007-07-08 |
4 |
D |
$25.58 |
$167,319 |
D/D |
(6,541) |
69,459 |
|
- |
|
| Batty John |
Chief Financial Officer |
• – – |
2007-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-06-15 |
4 |
AS |
$26.00 |
$260,000 |
D/D |
(10,000) |
16,195 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-06-15 |
4 |
OE |
$19.34 |
$193,350 |
D/D |
10,000 |
26,195 |
|
- |
|
| Young John A |
Director |
– • – |
2007-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,547 |
87,213 |
|
- |
|
| Wayman Robert Paul |
Director |
– • – |
2007-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,547 |
4,547 |
|
- |
|
| Trice Robert H |
Director |
– • – |
2007-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,547 |
4,547 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
16,195 |
|
- |
|
| Gibson James R Ii |
Principal Accounting Officer |
• – – |
2007-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,200 |
11,486 |
|
- |
|
| King Kevin M |
EVP & President, Life Sciences |
• – – |
2007-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
76,000 |
|
- |
|
| Fodor Stephen P A |
Chairman and CEO |
• • – |
2007-05-26 |
4 |
D |
$25.49 |
$34,998 |
D/D |
(1,373) |
72,897 |
|
- |
|
| Gibson James R Ii |
Principal Accounting Officer |
• – – |
2007-05-26 |
4 |
D |
$25.49 |
$5,455 |
D/D |
(214) |
9,286 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-05-26 |
4 |
D |
$25.49 |
$20,519 |
D/D |
(805) |
8,195 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-05-24 |
4 |
AS |
$26.02 |
$261,129 |
D/D |
(10,000) |
9,000 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-05-24 |
4 |
OE |
$19.34 |
$193,350 |
D/D |
10,000 |
19,000 |
|
- |
|
| Caulfield Barbara A |
EVP and General Counsel |
• – – |
2007-05-23 |
4 |
AS |
$26.00 |
$260,000 |
D/D |
(10,000) |
9,000 |
|
- |
|
641 Records found
|
|
Page 12 of 26 |
|
|
